CareCloud (NASDAQ:CCLD) Director John Daly Sells 15,000 Shares of Stock

CareCloud, Inc. (NASDAQ:CCLD) Director John Daly sold 15,000 shares of the stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $3.41, for a total transaction of $51,150.00. Following the completion of the sale, the director owned 51,750 shares of the company’s stock, valued at approximately $176,467.50. The trade was a 22.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

CareCloud Stock Down 1.1%

Shares of CareCloud stock traded down $0.04 on Thursday, hitting $3.17. 52,932 shares of the company traded hands, compared to its average volume of 587,310. CareCloud, Inc. has a 12-month low of $1.14 and a 12-month high of $4.84. The company has a market cap of $133.95 million, a PE ratio of -78.75 and a beta of 2.07. The company has a 50-day moving average price of $3.33 and a 200 day moving average price of $2.72.

CareCloud (NASDAQ:CCLD) last released its quarterly earnings data on Thursday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. CareCloud had a return on equity of 23.51% and a net margin of 10.08%.The firm had revenue of $31.07 million during the quarter, compared to analysts’ expectations of $29.01 million. Equities research analysts anticipate that CareCloud, Inc. will post 0.58 EPS for the current year.

Analyst Upgrades and Downgrades

CCLD has been the topic of a number of recent research reports. Roth Capital restated a “neutral” rating and set a $3.25 price target on shares of CareCloud in a report on Thursday, November 6th. Weiss Ratings restated a “sell (d+)” rating on shares of CareCloud in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $3.08.

Hedge Funds Weigh In On CareCloud

Institutional investors and hedge funds have recently bought and sold shares of the stock. Baader Bank Aktiengesellschaft acquired a new stake in CareCloud in the 3rd quarter worth $39,000. HighTower Advisors LLC bought a new stake in CareCloud in the first quarter valued at about $28,000. Vanguard Personalized Indexing Management LLC bought a new position in CareCloud during the second quarter worth about $50,000. XTX Topco Ltd bought a new stake in shares of CareCloud in the 1st quarter valued at approximately $35,000. Finally, Kingsview Wealth Management LLC acquired a new position in shares of CareCloud in the 1st quarter worth approximately $36,000. Institutional investors own 10.16% of the company’s stock.

About CareCloud

CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.